Article Versions Notes

Vela C, Jouve T, Chevallier E, Imerzoukene F, Germi R, Le Marechal M, Truffot A, Fiard G, Janbon B, Giovannini D, et al. Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study. Journal of Clinical Medicine. 2022; 11(24):7292. https://doi.org/10.3390/jcm11247292

Vela, Carla, Thomas Jouve, Eloi Chevallier, Farida Imerzoukene, Raphaële Germi, Marion Le Marechal, Aurélie Truffot, Gaëlle Fiard, Bénédicte Janbon, Diane Giovannini, and et al. 2022. "Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study" Journal of Clinical Medicine 11, no. 24: 7292. https://doi.org/10.3390/jcm11247292

Vela, C., Jouve, T., Chevallier, E., Imerzoukene, F., Germi, R., Le Marechal, M., Truffot, A., Fiard, G., Janbon, B., Giovannini, D., Malvezzi, P., Rostaing, L., & Noble, J. (2022). Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study. Journal of Clinical Medicine, 11(24), 7292. https://doi.org/10.3390/jcm11247292